My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

92.92 -0.01 (-0.01%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

MRK Investors Have the Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

April 13, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Deadline Soon: Merck & Co (MRK) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

April 11, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗

April 11, 2025

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.

Via Benzinga

Topics Government World Trade

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash ↗

April 10, 2025

Here's why the 90-day tariffs delay doesn't help pharmaceutical companies.

Via Investor's Business Daily

Topics Government Stocks World Trade

3 Robotics Stocks That Could Benefit From U.S. Manufacturing Boom

April 10, 2025

These robotics companies could find an opportunity if the latest round of tariffs stimulates an increase in U.S. manufacturing capacity.

Via MarketBeat

Topics Government World Trade

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline ↗

April 09, 2025

Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.

Via Benzinga

Topics Government Supply Chain World Trade

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

April 09, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

April 09, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

Via Chartmill

Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports ↗

April 09, 2025

Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports.

Via Investor's Business Daily

Topics Government Stocks World Trade

Trump Hints At 'Major Tariff' On Imported Pharmaceuticals: Pfizer, Eli Lilly, Amgen And Other Stocks Tumble In Wednesday Pre-Market ↗

April 09, 2025

President Donald Trump has declared that his administration is on the brink of imposing a significant tariff on pharmaceuticals imported from foreign countries.

Via Benzinga

Topics Government World Trade

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

April 09, 2025

Via The Motley Fool

Topics Intellectual Property Stocks World Trade

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

April 08, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Why Health Care Select Sector SPDR Fund (XLV) Is Moving ↗

April 07, 2025

Shares of the Health Care Select Sector SPDR Fund are trading lower by 8.6% over the past week. Tariff announcements from President Donald Trump last week spooked investors and have dragged major...

Via Benzinga

Topics Government

Is MERCK & CO. INC. (NYSE:MRK) a Good Fit for Dividend Investing? ↗

April 07, 2025

Uncovering Dividend Opportunities with MERCK & CO. INC. (NYSE:MRK).

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRK

April 07, 2025

From Pomerantz LLP

Via GlobeNewswire

2 Reasons to Like MRK (and 1 Not So Much)

April 07, 2025

The past six months haven’t been great for Merck. It just made a new 52-week low of $79.69, and shareholders have lost 26.6% of their capital. This was partly due to its softer quarterly results and...

Via StockStory

Topics Supply Chain

Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

April 06, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks ↗

April 04, 2025

Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

Via Benzinga

Topics Government World Trade

BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit ↗

April 03, 2025

BeiGene ends its Phase 3 lung cancer trial for ociperlimab after a futility analysis. No new safety concerns were found, and study results will be shared later.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRK

April 03, 2025

From Pomerantz LLP

Via GlobeNewswire

Biotech Stocks Dive After Trump Tacks On 20% European Tariff. Why AbbVie, Merck Could Be Exposed. ↗

April 02, 2025

It's unclear whether pharmaceutical goods could be exempt from tariffs. A number of drugmakers manufacture ingredients abroad.

Via Investor's Business Daily

Topics Economy Government World Trade

How Do Investors Really Feel About Merck & Co? ↗

April 02, 2025

Via Benzinga

MERCK & CO. INC. (NYSE:MRK) appears to be flying under the radar despite its strong fundamentals. ↗

April 02, 2025

MERCK & CO. INC. has a stellar value proposition. NYSE:MRK not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.

Via Chartmill

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

April 02, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

2 Beaten-Down Stocks to Buy and Hold for a Decade ↗

April 02, 2025

Via The Motley Fool

Topics Intellectual Property

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Intellia, and Merck and Encourages Investors to Contact the Firm

April 01, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Why Major Pharmaceutical Stocks Tumbled on Tuesday ↗

April 01, 2025

Via The Motley Fool

Topics Government World Trade

Exploring the top movers within the S&P500 index during today's session. ↗

April 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Via Chartmill

Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings ↗

April 01, 2025

Reports of mass firings include another high-profile official as Robert F. Kennedy Jr. and Marty Makary take up their new roles.

Via Investor's Business Daily

Topics Workforce

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

April 01, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition